----
Delay To be listed: Nov 16, 16:08:00Financials
FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.12.31
Overview: HEMAY PHARMA-B(00054) the EBIT is -143.73 M (-5.54%);the EPS is -0.358 (-4.13%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.14B5.54%
----
----
EPS
-0.35764.13%
----
----
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
